and formed germinal centers normally but were dramatition factors, Blimp-1 and XBP1. By gene expression cally impaired in their ability to secrete immunoglobulin profiling, we defined a set of genes whose induction in vitro and in vivo in response to T-dependent or during mouse plasmacytic differentiation is dependent -independent antigens. Most importantly, these xbp1-on Blimp-1 and/or XBP1. Blimp-1-deficient B cells deficient mice were devoid of plasma cells, demonstrafailed to upregulate most plasma cell-specific genes, ting the requirement for XBP1 in plasmacytic differentiincluding xbp1. Differentiating xbp1-deficient B cells ation. genes in the plasma cells, but the induction of plasma BiP is dissociated from PERK during an UPR, which cell genes was readily measured. After applying confiactivates PERK to phosphorylate the key translation inidence criteria for each element, we focused our analysis tiation factor eIF2␣. eIF2␣ phosphorylation acutely inon those genes that required prdm1 or xbp1 for maximal hibits protein translation globally, thereby lessening the induction and were also more highly expressed in load of proteins entering the ER. However Supplemental Figure S2 ). Figure 3A shows genes upregulated by XBP1-s but XBP1 Promotes ER Expansion To explore further the role of XBP1 in regulating gene not XBP1-u in Raji cells. XBP1-s induced many of the same genes that were found to be xbp1-dependent in expression, we used retroviral transduction to express human XBP1 in cell lines that lack expression of the the mouse (indicated by an "*"). Genes found to be prdm1-dependent but xbp1-independent in the mouse endogenous xbp1 gene. Retroviruses bearing a puromycin selectable marker were engineered to coexpress the (e.g., syndecan-1) were not induced by XBP1-s expression in Raji cells, supporting the notion that Blimp-1 transcriptionally active, processed form of human xbp1 mRNA (XBP1-s) or a form of xbp1 mRNA that cannot alone regulates these genes. Secretory pathway genes again dominate the list of XBP1-s-induced genes Figure S3) . 5B). The XBP1-induced increase in cell size was observed in both B cells (RAJI, WEHI231) and non-B cells Given the profound change in secretory pathway gene expression mediated by XBP1 in both mouse and human (WS1). Furthermore, knockdown of XBP1 expression in a myeloma cell line by RNA interference decreased cell cells, it seemed likely that it may also mediate an expansion of the ER and Golgi compartments. We observed size, demonstrating that in cells that constitutively express XBP1-s, XBP1 maintains cell size. XBP1-s expreschanges in the light scattering properties of cells expressing XBP1-s consistent with an increase in organsion also increased nuclear size and nucleolar prominence (yellow arrows, Figure 5B ). The increase in nuclear elle content, while interference with XBP1 expression in H929 myeloma cells resulted in a decrease in side scatsize was not due to increased DNA content or an arrest of cells in the G2/M phase of the cell cycle as determined ter ( Figure 4A ribosomal biogenesis, in XBP1-s-expressing cells (Figtween glycosylated and nonglycosylated proteins, we found that XBP1-s expression had little effect on nonglyure 5B, yellow arrows). However, it is not clear at present whether this increase in ribosomal content can account coprotein degradation, which remained near 9% across all samples ( Figure 6D ). This suggests that the XBP1-sfor the increased protein synthesis, since the overall loading of mRNAs onto polysomes in these cells was associated decrease in protein degradation is the result of a specific decrease in glycoprotein degradation. extremely low and therefore difficult to accurately quantitate by ultracentrifugation (data not shown).
, rag2
Ϫ/Ϫ chimeric mice were used to assess XBP1 function within the B cell lineage (Reimold et al.,
The differentiation of B cells into immunoglobulin-2001). These mice possessed B cells that proliferated secreting plasma cells is controlled by two transcrip-
and formed germinal centers normally but were dramatition factors, Blimp-1 and XBP1. By gene expression cally impaired in their ability to secrete immunoglobulin profiling, we defined a set of genes whose induction in vitro and in vivo in response to T-dependent or during mouse plasmacytic differentiation is dependent -independent antigens. Most importantly, these xbp1-on Blimp-1 and/or XBP1. Blimp-1-deficient B cells deficient mice were devoid of plasma cells, demonstrafailed to upregulate most plasma cell-specific genes, ting the requirement for XBP1 in plasmacytic differentiincluding xbp1. Differentiating xbp1-deficient B cells ation. sion that is triggered by perturbations in the function In addition, XBP1 increased cell size, lysosome conof the endoplasmic reticulum (ER). Experimentally, the tent, mitochondrial mass and function, ribosome num-UPR can be induced by DTT, which disrupts protein bers, and total protein synthesis. Thus, XBP1 coordifolding in the ER; tunicamycin, which disrupts glycosylanates diverse changes in cellular structure and tion and folding in the ER; and thapsigargin, which In the present study, we used gene expression profil-IRE1 phosphorylation is accompanied by activation of ing to study the terminal differentiation of B cells derived an endoribonuclease activity in its cytoplasmic domain, from Blimp-1-deficient and XBP1-deficient mice in order which mediates the posttranscriptional processing of to elucidate the roles of these transcription factors in the mRNA encoding HAC1, the yeast ortholog of XBP1. plasma cell development. We observed that XBP1 acted IRE1 removes a 252 nucleotide internal sequence from downstream of Blimp-1 to regulate a broad complement HAC1 mRNA, and tRNA ligase rejoins the two fragments of genes encoding ER-associated proteins, many of of HAC1 mRNA. This new version of HAC1 mRNA is which are involved in protein secretion. XBP1 induced translated more efficiently than the unprocessed form a dramatic physical expansion of the ER but also, genes in the plasma cells, but the induction of plasma BiP is dissociated from PERK during an UPR, which cell genes was readily measured. After applying confiactivates PERK to phosphorylate the key translation inidence criteria for each element, we focused our analysis tiation factor eIF2␣. eIF2␣ phosphorylation acutely inon those genes that required prdm1 or xbp1 for maximal hibits protein translation globally, thereby lessening the induction and were also more highly expressed in load of proteins entering the ER. However Supplemental Figure S2 ). Figure 3A shows genes upregulated by XBP1-s but XBP1 Promotes ER Expansion To explore further the role of XBP1 in regulating gene not XBP1-u in Raji cells. XBP1-s induced many of the same genes that were found to be xbp1-dependent in expression, we used retroviral transduction to express human XBP1 in cell lines that lack expression of the the mouse (indicated by an "*"). Genes found to be prdm1-dependent but xbp1-independent in the mouse endogenous xbp1 gene. Retroviruses bearing a puromycin selectable marker were engineered to coexpress the (e.g., syndecan-1) were not induced by XBP1-s expression in Raji cells, supporting the notion that Blimp-1 transcriptionally active, processed form of human xbp1 mRNA (XBP1-s) or a form of xbp1 mRNA that cannot alone regulates these genes. Secretory pathway genes again dominate the list of XBP1-s-induced genes Some (armet, prdx4, glrx1) were also identified in the were stained with DiOC6, a marker of ER and mitochondria ( Figure 4C ; Terasaki et al., 1984) . The stained area mouse differentiation system as xbp1 dependent. The consistent appearance of these genes in two indepenwas greatly expanded in cells expressing XBP1-s (white arrow). To further confirm the XBP1-s-driven ER expandent systems suggests conserved functions for XBP1-s beyond induction of secretory pathway genes. sion, we transiently expressed a green fluorescent protein (GFP) with an added signal sequence and KDEL ERWe further confirmed several of these genes as XBP1-s targets by independently measuring their inducretention motif in Raji control-and XBP1-s-expressing cells ( Figure 4D ). Consistent with the preceding results, tion using quantitative RT-PCR (Supplemental Figure  S3 ). The dependence of these genes on XBP1 expresthe ER-retained GFP painted a small area in control cells that expanded substantially when XBP1-s was exsion was also confirmed by RNA interference. Expression of an shRNA directed against XBP1 in the XBP1-pressed. During our analysis of XBP1-induced ER expansion, expressing human multiple myeloma line H929 decreased XBP1 expression by nearly 3-fold and shows a concomiwe also noted that cell size increased dramatically, as quantitated by measuring cell diameter (Figures 5A and tant drop in expression of ER-related and other XBP1-s-induced genes (Supplemental Figure S3) . 5B). The XBP1-induced increase in cell size was observed in both B cells (RAJI, WEHI231) and non-B cells Given the profound change in secretory pathway gene expression mediated by XBP1 in both mouse and human (WS1). Furthermore, knockdown of XBP1 expression in a myeloma cell line by RNA interference decreased cell cells, it seemed likely that it may also mediate an expansion of the ER and Golgi compartments. We observed size, demonstrating that in cells that constitutively express XBP1-s, XBP1 maintains cell size. XBP1-s expreschanges in the light scattering properties of cells expressing XBP1-s consistent with an increase in organsion also increased nuclear size and nucleolar prominence (yellow arrows, Figure 5B ). The increase in nuclear elle content, while interference with XBP1 expression in H929 myeloma cells resulted in a decrease in side scatsize was not due to increased DNA content or an arrest of cells in the G2/M phase of the cell cycle as determined ter ( Figure 4A 
ribosomal biogenesis, in XBP1-s-expressing cells (Figtween glycosylated and nonglycosylated proteins, we
found that XBP1-s expression had little effect on nonglyure 5B, yellow arrows). However, it is not clear at present whether this increase in ribosomal content can account coprotein degradation, which remained near 9% across all samples ( Figure 6D ). This suggests that the XBP1-sfor the increased protein synthesis, since the overall loading of mRNAs onto polysomes in these cells was associated decrease in protein degradation is the result of a specific decrease in glycoprotein degradation. extremely low and therefore difficult to accurately quantitate by ultracentrifugation (data not shown).
We next examined the effects of XBP1-s on protein degradation in Raji cells by radiolabeling cells for 5 min
Discussion with 35 
S-methionine and chasing with unlabeled methionine for 30 min. Protein degradation was monitored by
We have used gene expression profiling to understand how two transcription factors, Blimp-1 and XBP1, conmeasuring the loss of cell-associated and secreted TCAinsoluble radioactivity in the presence and absence of trol plasma cell differentiation. Most plasma cell genes were under the control of Blimp-1. Many of these were the proteosome inhibitor MG132 over time. In control cells, over 30% of labeled proteins were degraded duralso targets of XBP1 and promote the entry, processing, and movement of proteins through the secretory pathing the 30 min chase period ( Figure 6D) , which reflects the rapid proteasome-mediated destruction of newly way. Furthermore, XBP1 expression was sufficient to induce many phenotypic changes that characterize synthesized proteins (Schubert et al., 2000) . Expression of XBP1-s reduced the fraction of rapidly degraded plasmacytic differentiation: increased cell size, expanded organelle mass and function, and increased pronewly synthesized proteins by approximately 40%, from 31% in control cells to 19% with XBP1-s expression, tein synthesis. These findings suggest that the role of XBP1 in higher eukaryotes has been extended beyond whereas expression of XBP1-u had little effect on the rate of degradation. Using ConA to discriminate beits role in the ER stress response and that XBP1 may Figures 1 and 2) . Blimp-1 but not cluding sdc1, which encodes the standard plasma cell pholipid biosynthesis. Since not every secretory pathThe present study defines an expanded role for XBP1 way gene was upregulated by the UPR in yeast, HAC1 in enhancing the secretory capacity of plasma cells. A may be devoted to remodeling the secretory pathway remarkably consistent set of XBP1 target genes to specifically cope with an excess of unfolded proteins emerged from studies of xbp1-deficient mouse B cells (Travers et al., 2000) . Another interesting aspect of this and ectopic XBP1 expression, many of which encode study was the finding that mutations in the UPR pathway and the ERAD pathway were synthetically lethal under proteins that function in the secretory pathway. Our data normal growth conditions, revealing a role for HAC1 and Therefore, the increase in protein synthesis caused by XBP1 cannot be explained by upregulation of mRNAs the "UPR" in the absence of overt ER stress.
XBP1 has not only retained the broad, UPR-related, encoding glycosylated proteins in the secretory pathway but must be due to a more general mechanism. transcriptional program of HAC1 but also has the ability to physically expand the ER compartment. In both Another unanticipated observation was that XBP1 instress is severe and prolonged. XBP1, on the other hand, has apparently evolved to promote translation by antagcreased protein synthesis globally by 30%-50%, which could contribute to the increase in organelle content onizing PERK, thereby allowing cells to differentiate into professional secretory cells that can tolerate a constituand cell size. XBP1-s increased the synthesis of both nonglycosylated and glycosylated proteins equivalently.
tively high throughput of ER proteins.
Flow Cytometry and Microscopy
It may therefore be helpful to define a "physiological" 
